Exai Bio secures $67.5 million series A financing to advance next-generation, RNA-based liquid biopsy platform for early cancer detection

December 10, 2021 Leave a comment 1,674 Views

Exai Bio, a next-generation liquid biopsy company, today announced it has raised a $67.5 million Series A financing to accelerate development of its non...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Exai Bio

Exai Bio secures $67.5 million series A financing to advance next-generation, RNA-based liquid biopsy platform for early cancer detection

spSeudoMap – cell type mapping of spatial transcriptomics using unmatched single-cell RNA-seq data

SoCube – an innovative end-to-end doublet detection algorithm for analyzing scRNA-seq data

Quantabio adds powerful bead booster chemistry to ultra-fast sparQ RNA-Seq HMR kit

SiT – spatial isoform transcriptomics

Analysis of single-cell rna-seq data

AllenDigger – spatial expression data visualization, spatial heterogeneity delineation, and single-cell registration based on the Allen Brain Atlas

New research identifies an inaccuracy in the single cell GENCODE gene model